Evolutionary foundations for cancer biology

Evolutionary Applications

Volumn 6, Issue 1, 2013, Pages 144-159

  Aktipis, C Athena ^a,b   Nesse, Randolph M ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Darwinian; Ecological; Evolutionary medicine; Mismatch; Neoplastic; Vulnerability

Indexed keywords

EID: 84872828101     PISSN: 17524563     EISSN: 17524571     Source Type: Journal    
DOI: 10.1111/eva.12034     Document Type: Note

References (133)

1. Aktipis, C. A., C. C. Maley, and S. L. Neuberg 2010. Psychological barriers to evolutionary thinking in medicine. Evolution and Medicine Review.
2. Aktipis, C. A., V. S. Kwan, K. A. Johnson, S. L. Neuberg, and C. C. Maley 2011. Overlooking evolution: a systematic analysis of cancer relapse and therapeutic resistance research. PLoS ONE 6:e26100. doi: 10.1371/journal.pone.0026100.
3. Aktipis, C. A., C. C. Maley, and J. W. Pepper 2012. Dispersal evolution in neoplasms: the role of disregulated metabolism in the evolution of cell motility. Cancer Prevention Research (Philadelphia, Pa.) 5:266-275. doi: 10.1158/1940-6207.CAPR-11-0004.
4. Alcock, J. 2009. Animal behavior: an evolutionary approach. 9th ed. Sinauer Associates, Sunderland, Mass.
5. Alfarouk, K. O., M. E Ibrahim, R. A. Gatenby, and J. S. Brown this issue. Riparian ecosystems in human cancers. Evolutionary Applications In this issue.
6. Althuis, M. D., J. H. Fergenbaum, M. Garcia-Closas, L. A. Brinton, M. P. Madigan, and M. E. Sherman 2004. Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiology, Biomarkers & Prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 13:1558-1568. doi: 13/10/1558 [pii].
7. American Cancer Society. 2012. Cancer Facts & Figures 2012. Atlanta.
8. Anderson, K., C. Lutz, F. W. van Delft, C. M. Bateman, Y. Guo, S. M. Colman, H. Kempski et al. 2011. Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature 469:356-361. doi: 10.1038/nature09650.
9. Archie, E. A., J. Altmann, and S. C. Alberts 2012. Social status predicts wound healing in wild baboons. Proceedings of the National Academy of Sciences of the United States of America 109:9017-9022. doi: 10.1073/pnas.1206391109.
10. Arthur, J. C., and C. Jobin 2011. The struggle within: microbial influences on colorectal cancer. Inflammatory bowel diseases 17:396-409. doi: 10.1002/ibd.21354.
11. Axelrod, R., D. E. Axelrod, and K. J. Pienta 2006. Evolution of cooperation among tumor cells. Proceedings of the National Academy of Sciences of the United States of America 103:13474-13479. doi: 10.1073/pnas.0606053103.
12. Bauer, K. R., M. Brown, R. D. Cress, C. A. Parise, and V. Caggiano 2007. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer 109:1721-1728. doi: 10.1002/cncr.22618.
13. Beaber, E. F., V. L. Holt, K. E. Malone, P. L. Porter, J. R. Daling, and C. I. Li 2008. Reproductive factors, age at maximum height, and risk of three histologic types of breast cancer. Cancer Epidemiology, Biomarkers & Prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 17:3427-3434. doi: 17/12/3427 [pii]10.1158/1055-9965.EPI-08-0641.
14. Beckman, R. A., and L. A. Loeb 2005. Negative clonal selection in tumor evolution. Genetics 171:2123-2131. doi: 10.1534/genetics.105.040840.
15. Bissell, M. J., and W. C. Hines 2011. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression Nature medicine 17:320-329. doi: 10.1038/nm.2328.
16. Bissell, M. J., and D. Radisky 2001. Putting tumours in context. Nature reviews. Cancer 1:46-54. doi: 10.1038/35094059.
17. Blask, D. E., G. C. Brainard, R. T. Dauchy, J. P. Hanifin, L. K. Davidson, J. A. Krause, L. A. Sauer et al. 2005. Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer research 65:11174-11184. doi: 10.1158/0008-5472.CAN-05-1945.
18. Calistro Alvarado, L. this issue. An Evolutionary Perspective on Population Differences in Men's Testosterone Secretion and Prostate Cancer Disparities. Evolutionary Applications In this issue.
19. Campbell, P. J., E. D. Pleasance, P. J. Stephens, E. Dicks, R. Rance, I. Goodhead, G. A. Follows et al. 2008. Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing. Proceedings of the National Academy of Sciences of the United States of America 105:13081-13086. doi: 10.1073/pnas.0801523105.
20. Cancer Research UK. 2012. Cancer incidence by age 2012. http://www.cancerresearchuk.org/cancer-info/cancerstats/incidence/age/ (accessedon 30 September 2012).
21. Caulin, A. F., and C. C. Maley 2011. Peto's Paradox: evolution's prescription for cancer prevention. Trends in ecology & evolution 26:175-182. doi: 10.1016/j.tree.2011.01.002.
22. Cavallo, F., C. De Giovanni, P. Nanni, G. Forni, and P. L. Lollini 2011. The immune hallmarks of cancer. Cancer Immunology, Immunotherapy: CII 60:319-326. doi: 10.1007/s00262-010-0968-0.
23. Chen, J., K. Sprouffske, Q. Huang, and C. C. Maley 2011. Solving the puzzle of metastasis: the evolution of cell migration in neoplasms. PLoS ONE 6:e17933. doi: 10.1371/journal.pone.0017933.
24. Coe, K., and L. Steadman 1995. The human breast and the ancestral reproductive cycle. Human Nature 6:197-220. doi: 10.1007/bf02734139.
25. Colditz, G. A., B. A. Rosner, W. Y. Chen, M. D. Holmes, and S. E. Hankinson 2004. Risk factors for breast cancer according to estrogen and progesterone receptor status. Journal of the National Cancer Institute 96:218-228.
26. Cooper, G. M., and R. E. Hausman 2009. The cell: a molecular approach. 4th ed. ASM Press, Sinauer Associates, Washington, D.C, Sunderland, Mass.
27. Correia, A. L., and M. J. Bissell 2012. The tumor microenvironment is a dominant force in multidrug resistance. Drug Resistance Updates: Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy 15:39-49. doi: 10.1016/j.drup.2012.01.006.
28. Coussens, L. M., and Z. Werb 2002. Inflammation and cancer. Nature 420:860-867. doi: 10.1038/nature01322.
29. Crespi, B., and K. Summers 2005. Evolutionary biology of cancer. Trends in ecology & evolution 20:545-552. doi: 10.1016/j.tree.2005.07.007.
30. Daoust, S. P., L. Fahrig, A. Martin, and F. Thomas this issue. From forest and agro-ecosystems to the microecosystems of the human body: what can landscape ecology tell us about tumor growth, metastasis and treatment options? Evolutionary Applications In this issue.
31. David, A. R., and M. R. Zimmerman 2010. Cancer: an old disease, a new disease or something in between?Nature reviews. Cancer 10:728-733. doi: 10.1038/nrc2914.
32. Dawood, S. 2010. Triple-negative breast cancer: epidemiology and management options. Drugs 70:2247-2258. doi: 4 [pii] 10.2165/11538150-000000000-00000.
33. De Stavola, B. L., I. dos Santos Silva, V. McCormack, R. J. Hardy, D. J. Kuh, and M. E. Wadsworth 2004. Childhood growth and breast cancer. American journal of epidemiology 159:671-682.
34. Dolle, J. M., J. R. Daling, E. White, L. A. Brinton, D. R. Doody, P. L. Porter, and K. E. Malone 2009. Risk factors for triple-negative breast cancer in women under the age of 45 years. Cancer Epidemiology, Biomarkers & Prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 18:1157-1166. doi: 1055-9965.EPI-08-1005 [pii] 10.1158/1055-9965.EPI-08-1005.
35. Dyer, M. A., and R. Bremner 2005. The search for the retinoblastoma cell of origin. Nature reviews. Cancer 5:91-101. doi: 10.1038/nrc1545.
36. Eaton, S. B., M. C. Pike, R. V. Short, N. C. Lee, J. Trussell, R. A. Hatcher, J. W. Wood et al., et al. 1994. Women's reproductive cancers in evolutionary context. The Quarterly review of biology 69:353-367.
37. Eckburg, P. B., E. M. Bik, C. N. Bernstein, E. Purdom, L. Dethlefsen, M. Sargent, S. R. Gill et al. 2005. Diversity of the human intestinal microbial flora. Science 308:1635-1638. doi: 10.1126/science.1110591.
38. Elias, S. G., P. H. Peeters, D. E. Grobbee, and P. A. van Noord 2004. Breast cancer risk after caloric restriction during the 1944-1945 Dutch famine. Journal of the National Cancer Institute 96:539-546.
39. Ewald, P. W., and H. A. Swain Ewald this issue. Toward a general evolutionary theory of oncogenesis. Evolutionary Applications In this issue.
40. Fernandez, A. A. 2010. A cancer-causing gene is positively correlated with male aggression in Xiphophorus cortezi. Journal of evolutionary biology 23:386-396. doi: 10.1111/j.1420-9101.2009.01914.x.
41. Fisher, R. A. 1930. The genetical theory of natural selection. The Clarendon press: Oxford.
42. Foo, J., K. Leder, and M. Shannon this issue. Cancer as a moving targe: Understanding the composition and rebound growth kinetics of recurrent tumors. Evolutionary Applications In this issue.
43. Foulkes, W. D., I. E. Smith, and J. S. Reis-Filho 2010. Triple-negative breast cancer. New England Journal of Medicine 363:1938-1948. doi: 10.1056/NEJMra1001389.
44. Frank, S. A. 2007a. Dynamics of Cancer: Incidence, Inheritance, and Evolution. Princeton University Press, Princeton (NJ).
45. Frank, S. A. 2007b. Dynamics of cancer: incidence, inheritance, and evolution, Princeton series in evolutionary biology. Princeton University Press, Princeton, N.J.
46. Frank, S. A. 2010. Evolution in health and medicine Sackler colloquium: Somatic evolutionary genomics: mutations during development cause highly variable genetic mosaicism with risk of cancer and neurodegeneration. Proceedings of the National Academy of Sciences of the United States of America 107(Suppl 1):1725-1730. doi: 10.1073/pnas.0909343106.
47. Gabrilovich, D., and V. Pisarev 2003. Tumor escape from immune response: mechanisms and targets of activity. Current drug targets 4:525-536.
48. Garcia-Cao, I., M. Garcia-Cao, J. Martin-Caballero, L. M. Criado, P. Klatt, J. M. Flores, J. C. Weill et al. 2002. "Super p53" mice exhibit enhanced DNA damage response, are tumor resistant and age normally. The EMBO Journal 21:6225-6235.
49. Gluckman, P., A. Beedle, and M. Hanson 2009. Principles of Evolutionary Medicine. Oxford University Press, USA.
50. Gatenby, R. A. 2009. A change of strategy in the war on cancer. Nature 459:508-509. doi: 10.1038/459508a.
51. Gatenby, R. A., and R. J. Gillies 2008. A microenvironmental model of carcinogenesis. Nature reviews. Cancer 8:56-61. doi: 10.1038/nrc2255.
52. Gatenby, R. A., A. S. Silva, R. J. Gillies, and B. R. Frieden 2009. Adaptive therapy. Cancer research 69:4894-4903. doi: 10.1158/0008-5472.CAN-08-3658.
53. Gatenby, R. A., R. J. Gillies, and J. S. Brown 2010. Evolutionary dynamics of cancer prevention. Nature reviews. Cancer 10:526-527.
54. Gerlinger, M., A. J. Rowan, S. Horswell, J. Larkin, D. Endesfelder, E. Gronroos, P. Martinez et al. 2012. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. The New England journal of medicine 366:883-892. doi: 10.1056/NEJMoa1113205.
55. Graham, T., R. Datta, A. Gutteridge, C. Swanton, and C. Maley this issue. Modelling the evolution of genetic instability during tumour progression. Evolutionary Applications In this issue.
56. Greaves, M. this issue. Cancer stem cells as 'units of selection'. Evolutionary Applications In this issue.
57. Greaves, M. F., and L. Kinlen 2000. Cancer: the Evolutionary Legacy, Oxford University Press, Oxford.
58. Greaves, M. 2007. Darwinian medicine: a case for cancer. Nature reviews. Cancer 7:213-221.
59. Greaves, M., and C. C. Maley 2012. Clonal evolution in cancer. Nature 481:306-313. doi: 10.1038/nature10762.
60. Grepin, R., and G. Pages 2010. Molecular mechanisms of resistance to tumour anti-angiogenic strategies. Journal of Oncology 2010:835680. doi: 10.1155/2010/835680.
61. Grivennikov, S. I., F. R. Greten, and M. Karin 2010. Immunity, inflammation, and cancer. Cell 140:883-899. doi: 10.1016/j.cell.2010.01.025.
62. Guo, S., and L. A. Dipietro 2010. Factors affecting wound healing. Journal of dental research 89:219-229. doi: 10.1177/0022034509359125.
63. Hanahan, D., and Weinberg, R. A. 2000. The Hallmarks of Cancer. Cell 100:57-70.
64. Hansson, G. C. 2012. Role of mucus layers in gut infection and inflammation. Current opinion in microbiology 15:57-62. doi: 10.1016/j.mib.2011.11.002.
65. Hardin, G. 1968. The Tragedy of the Commons. Science 162:1243-1248.
66. Hartwell, L. H., and M. B. Kastan 1994. Cell cycle control and cancer. Science 266:1821-1828.
67. Hermes, G. L., and M. K. McClintock 2008. Isolation and the timing of mammary gland development, gonadarche, and ovarian senescence: implications for mammary tumor burden. Developmental Psychobiology 50:353-360. doi: 10.1002/dev.20295.
68. Hochberg, M. E., F. Thomas, E. Assenat, and U. Hibner this issue. Preventive Evolutionary Medicine of Cancers. Evolutionary Applications In this issue.
69. Hofman, P., and V. Vouret-Craviari 2012. Microbes-induced EMT at the crossroad of inflammation and cancer. Gut Microbes 3:176-185. doi: 10.4161/gmic.20288.
70. Hsieh, C. C., D. Trichopoulos, K. Katsouyanni, and S. Yuasa 1990. Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: associations and interactions in an international case-control study. International Journal of Cancer. Journal International Du Cancer 46:796-800.
71. Jablonski, N. G. 2004. The evolution of human skin and skin color. Annual Review of Anthropology 33:585-623. doi:10.1146/annurev.anthro.33.070203.143955.
72. Jablonski, N. G., and G. Chaplin 2010. Colloquium paper: human skin pigmentation as an adaptation to UV radiation. Proceedings of the National Academy of Sciences of the United States of America 107(Suppl 2):8962-8968. doi: 10.1073/pnas.0914628107.
73. Jasienska, G., and I. Thune 2001. Lifestyle, hormones, and risk of breast cancer. BMJ 322:586-587.
74. Kareva, I. 2011. What can ecology teach us about cancer? Translational oncology 4:266-270.
75. Keinan-Boker, L., N. Vin-Raviv, I. Liphshitz, S. Linn, and M. Barchana 2009. Cancer incidence in Israeli Jewish survivors of World War II. Journal of the National Cancer Institute 101:1489-1500. doi: djp327 [pii] 10.1093/jnci/djp327.
76. Koboldt, D. C., R. S. Fulton, M. D. McLellan, H. Schmidt, J. Kalicki-Veizer, J. F. McMichael, L. L. Fulton, et al. 2012. Comprehensive molecular portraits of human breast tumours. Nature 490:61-70.
77. Koupil, I., S. Plavinskaja, N. Parfenova, D. B. Shestov, P. D. Danziger, and D. Vagero 2009. Cancer mortality in women and men who survived the siege of Leningrad (1941-1944). International Journal of Cancer. Journal International Du Cancer 124:1416-1421. doi: 10.1002/ijc.24093.
78. Kruger, Daniel, and Randolph Nesse 2006. An evolutionary life-history framework for understanding sex differences in human mortality rates. Human nature 17:74-97. doi: 10.1007/s12110-006-1021-z.
79. Lee, A. J., and C. Swanton 2012. Tumour heterogeneity and drug resistance: personalising cancer medicine through functional genomics. Biochemical pharmacology 83:1013-1020. doi: 10.1016/j.bcp.2011.12.008.
80. Levine, D. S., C. E. Rubin, B. J. Reid, and R. C. Haggitt 1989. Specialized metaplastic columnar epithelium in Barrett's esophagus. A comparative transmission electron microscopic study. Laboratory Investigation; A Journal of Technical Methods and Pathology 60:418-432.
81. Maley, C. C., P. C. Galipeau, J. C. Finley, V. J. Wongsurawat, X. Li, C. A. Sanchez, T. G. Paulson et al. 2006. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nature genetics 38:468-473. doi: 10.1038/ng1768.
82. Mapara, M. Y., and M. Sykes 2004. Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 22:1136-1151. doi: 10.1200/JCO.2004.10.041.
83. Maynard Smith, J., and E., Szathmáry 1995a. The major transitions in evolution. W.H. Freeman Spektrum, Oxford.
84. Maynard Smith, J., and E., Szathmáry 1995b. The Major Transitions in Evolution. Oxford University Press, Oxford.
85. Melo, J. V., and D. J. Barnes 2007. Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nature reviews. Cancer 7:441-453. doi: 10.1038/nrc2147.
86. Merlo, L. M., and C. C. Maley 2010. The role of genetic diversity in cancer. The Journal of clinical investigation 120:401-403. doi: 10.1172/JCI42088.
87. Merlo, L. F., J. W. Pepper, B. J. Reid, and C. C. Maley 2006. Cancer as an evolutionary and ecological process. Nature reviews Cancer 6:924-935.
88. Merlo, L. M., N. A. Shah, X. Li, P. L. Blount, T. L. Vaughan, B. J. Reid, and C. C. Maley 2010. A comprehensive survey of clonal diversity measures in Barrett's esophagus as biomarkers of progression to esophageal adenocarcinoma. Cancer prevention research 3:1388-1397. doi: 10.1158/1940-6207.CAPR-10-0108.
89. Meza, R., E. G. Luebeck, and S. H. Moolgavkar 2005. Gestational mutations and carcinogenesis. Mathematical biosciences 197:188-210. doi: 10.1016/j.mbs.2005.06.003.
90. Nagy, J. A., A. M. Dvorak, and H. F. Dvorak 2012. Vascular hyperpermeability, angiogenesis, and stroma generation. Cold Spring Harbor perspectives in medicine 2:a006544. doi: 10.1101/cshperspect.a006544.
91. Nakasone, E. S., H. A. Askautrud, T. Kees, J. H. Park, V. Plaks, A. J. Ewald, M. Fein et al. 2012. Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance. Cancer Cell 21:488-503. doi: 10.1016/j.ccr.2012.02.017.
92. Navin, N., J. Kendall, J. Troge, P. Andrews, L. Rodgers, J. McIndoo, K. Cook et al. 2011. Tumour evolution inferred by single-cell sequencing. Nature 472:90-94. doi: 10.1038/nature09807.
93. Nedelcu, A. M. 2009. Environmentally induced responses co-opted for reproductive altruism. Biology letters 5:805-808. doi: 10.1098/rsbl.2009.0334.
94. Nerlich, A. G., H. Rohrbach, B. Bachmeier, and A. Zink 2006. Malignant tumors in two ancient populations: An approach to historical tumor epidemiology. Oncology reports 16:197-202.
95. Nesse, R. M. 2005. Maladaptation and natural selection. The Quarterly review of biology 80:62-70.
96. Nesse, R. M. and C. S. Stearns 2008. The great opportunity: evolutionary applications to medicine and public health. Evolutionary Applications 1:28-48.
97. Nesse, R. M., and G. C. Williams 1994. Why we get sick: The new science of Darwinian medicine. 1st ed. Times Books: New York.
98. Nik-Zainal, S., P. Van Loo, D. C. Wedge, L. B. Alexandrov, C. D. Greenman, K. W. Lau, K. Raine, et al. 2012. The life history of 21 breast cancers. Cell 149:994-1007. doi: 10.1016/j.cell.2012.04.023.
99. Nowell, P. C. 1976. The clonal evolution of tumor cell populations. Science 194:23-28.
100. Nunney, L. this issue. The real war on cancer: the evolutionary dynamics of cancer suppression. Evolutionary Applications In this issue.
101. Park, S. Y., M. Gonen, H. J. Kim, F. Michor, and K. Polyak 2010. Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. The Journal of clinical investigation 120:636-644. doi: 10.1172/JCI40724.
102. Pepper, J. W. 2012. Drugs that target pathogen public goods are robust against evolved drug resistance. Evolutionary Applications 5:757-761.
103. Pepper, J. W., S. C. Findlay, R. Kassen, S. L. Spencer, and C. C. Maley 2009. Cancer research meets evolutionary biology. Evolutionary Applications 2:62-70.
104. Peterson, J., S. Garges, M. Giovanni, P. McInnes, L. Wang, J. A. Schloss, V. Bonazzi, et al. 2009. The NIH Human Microbiome Project. Genome research 19:2317-2323. doi: 10.1101/gr.096651.109.
105. Peto, R., S. Darby, H. Deo, P. Silcocks, E. Whitley, and R. Doll 2000. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 321:323-329.
106. Pienta, K. J., N. McGregor, R. Axelrod, and D. E. Axelrod 2008. Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments. Translational Oncology 1:158-164.
107. Pontiggia, O., R. Sampayo, D. Raffo, A. Motter, R. Xu, M. J. Bissell, E. B. Joffe et al. 2012. The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through beta1 integrin. Breast cancer research and treatment 133:459-471. doi: 10.1007/s10549-011-1766-x.
108. Reiter, J. G., I. Bozic, B. Allen, K. Chatterjee, and M. A. Nowak this issue. The effect of one additional driver mutation on tumor progression. Evolutionary Applications In this issue.
109. Roche, B., K. Sprouffske, H. Hbid, D. Missé, M. Hochberg, and F. Thomas this issue. Peto's paradox revisited: theoretical evolutionary dynamics of cancer in wildlife. Evolutionary Applications In this issue.
110. Rogers, A. B. 2011. Distance burning: how gut microbes promote extraintestinal cancers. Gut Microbes 2:52-57. doi: 10.4161/gmic.2.1.14761.
111. Sauer, L. A., R. T. Dauchy, D. E. Blask, J. A. Krause, L. K. Davidson, and E. M. Dauchy 2005. Eicosapentaenoic acid suppresses cell proliferation in MCF-7 human breast cancer xenografts in nude rats via a pertussis toxin-sensitive signal transduction pathway. The Journal of Nutrition 135:2124-2129.
112. Shen, X. J., J. F. Rawls, T. Randall, L. Burcal, C. N. Mpande, N. Jenkins, B. Jovov et al. 2010. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes 1:138-147. doi: 10.4161/gmic.1.3.12360.
113. Smith, K. R., H. A. Hanson, G. P. Mineau, and S. S. Buys 2011. Effects of BRCA1 and BRCA2 mutations on female fertility. Proceedings. Biological Sciences/The Royal Society. doi: 10.1098/rspb.2011.1697.
114. Sprouffske, K., C. A. Aktipis, J. P. Radich, M. Carroll, A. M. Nedelcu, and C. C. Maley this issue. An evolutionary explanation for the presence of cancer non-stem cells in neoplasms. Evolutionary Applications In this issue.
115. Srivastava, A., J. L. Hornick, X. Li, P. L. Blount, C. A. Sanchez, D. S. Cowan, K. Ayub et al. 2007. Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus. The American Journal of Gastroenterology 102:483-493. quiz 694. doi: 10.1111/j.1572-0241.2007.01073.x.
116. Stanton, S. J., and O. C. Schultheiss 2007. Basal and dynamic relationships between implicit power motivation and estradiol in women. Hormones and behavior 52:571-580. doi: 10.1016/j.yhbeh.2007.07.002.
117. Stearns, S. C. 2000. Life history evolution: successes, limitations, and prospects. Die Naturwissenschaften 87:476-486.
118. Stearns, S. C., and J. C. Koella 2008. Evolution in Health and Disease, Oxford University Press, USA.
119. Stephens, P. J., C. D. Greenman, B. Fu, F. Yang, G. R. Bignell, L. J. Mudie, E. D. Pleasance, et al. 2011. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144:27-40. doi: 10.1016/j.cell.2010.11.055.
120. Strassmann, B. I. 1999. Menstrual cycling and breast cancer: an evolutionary perspective. Journal of Women's Health/The Official Publication of the Society for the Advancement of Women's Health Research 8:193-202.
121. Takubo, K., J. M. Nixon, and J. R. Jass 1995. Ducts of esophageal glands proper and paneth cells in Barrett's esophagus: frequency in biopsy specimens. Pathology 27:315-317.
122. Thomas, F., D. Fisher, P. Fort, J.-P. Marie, S. Daust, B. Roche, and C. Grunau, et al. this issue. Applying ecological and evolutionary theory to cancer: A long and winding road. Evolutionary Applications In this issue.
123. Tomlinson, M., L. Swartz, L. M. Kruger, and O. Gureje 2007. Manifestations of affective disturbance in sub-Saharan Africa: key themes. Journal of affective disorders 102:191-198. doi: 10.1016/j.jad.2006.09.029.
124. Tooby, J. 2011. Cancer as the product of two host-parasite coevolutionary races. First International Biannual Evolution and Cancer Conference. June. 3-5. University of California, San Francisco.
125. Tyner, S. D., S. Venkatachalam, J. Choi, S. Jones, N. Ghebranious, H. Igelmann, X. Lu, et al. 2002. p53 mutant mice that display early ageing-associated phenotypes. Nature 415:45-53. doi: 10.1038/415045a.
126. Van den Abbeele, P., S. Roos, V. Eeckhaut, D. A. MacKenzie, M. Derde, W. Verstraete, M. Marzorati et al. 2012. Incorporating a mucosal environment in a dynamic gut model results in a more representative colonization by lactobacilli. Microbial biotechnology 5:106-115. doi: 10.1111/j.1751-7915.2011.00308.x.
127. de Visser, K. E., A. Eichten, and L. M. Coussens 2006. Paradoxical roles of the immune system during cancer development. Nature reviews. Cancer 6:24-37. doi: 10.1038/nrc1782.
128. Williams, G. C., and R. M. Nesse 1991. The dawn of Darwinian medicine. Quarterly Review of Biology 66: 1-22.
129. Williams, P. D. 2010. Darwinian interventions: taming pathogens through evolutionary ecology. Trends in Parasitology 26:83-92. doi: 10.1016/j.pt.2009.11.009.
130. Williams, J. B., D. Pang, B. Delgado, M. Kocherginsky, M. Tretiakova, T. Krausz, D. Pan et al. 2009. A model of gene-environment interaction reveals altered mammary gland gene expression and increased tumor growth following social isolation. Cancer prevention research 2:850-861. doi: 10.1158/1940-6207.CAPR-08-0238.
131. Wolin, K. Y., K. Carson, and G. A. Colditz 2010. Obesity and cancer. The oncologist 15:556-565. doi: 10.1634/theoncologist.2009-0285.
132. Yang, L., X. Lu, C. W. Nossa, F. Francois, R. M. Peek, and Z. Pei 2009. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology 137:588-597. doi: 10.1053/j.gastro.2009.04.046.
133. Yu, L. C., J. T. Wang, S. C. Wei, and Y. H. Ni 2012. Host-microbial interactions and regulation of intestinal epithelial barrier function: from physiology to pathology. World Journal of Gastrointestinal Pathophysiology 3:27-43. doi: 10.4291/wjgp.v3.i1.27.